Authors


Tara K. Iyer, MD

Latest:

Educating Patients and Providers: Key Takeaways for Better VMS Management

Panelists discuss how providers should actively screen for vasomotor symptoms (VMS), especially given the lengthy wait times to see specialists, emphasizing that education for both patients and health care providers is essential for timely intervention and effective management.


Christine Blank

Latest:

WHO Guideline Update Recommends Against 2 COVID-19 Monoclonal Treatments

WHO: Evidence is lacking for clinical effectiveness of Xevudy and Regen-Cov against the COVID-19 variants that are currently circulating.


Amy Burton, MD

Latest:

Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab

The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.


Jeanne Caligiuri, MD

Latest:

Patient Cases Highlighting Integration of OSA Treatments into Practice

Panelists discuss how real-world patient cases demonstrate the importance of individualizing obstructive sleep apnea treatment plans by considering factors such as disease severity, comorbidities, lifestyle, and patient preferences to optimize outcomes.



Jennifer Seger, MD

Latest:

Antiobesity Medication: An Effective Treatment Tool for the Right Patient

Obesity requires a spectrum of treatment options for effective results. Here, 3 key points to keep in mind when considering antiobesity medication for patients.


Michelle L. Look, MD

Latest:

Early Intervention in Weight Management: Treating Pre-Obesity

Research shows that increased risk of chronic disease and mortality begins below a BMI classified as obesity. The earlier we intervene with at-risk patients, the greater the chance for success.


Elizabeth Holt, MD, FACE

Latest:

Take-Home Thoughts for Managing Diabetes

Eden Miller, DO, shares key takeaways on how personalized treatment helps in the management of diabetes.


Skylar Jeremias

Latest:

Cognitive Aging Research Program Reveals Insights Based on 25 Years of Data

A 25-year study of the Lothian Birth Cohorts found that childhood intelligence, lifestyle factors, and brain health significantly impact cognitive aging and longevity.


Austin Littrell

Latest:

America Leads High-Income Countries for Avoidable Deaths

Rates of preventable deaths are rising in every US state, according to a new study, defying the country's top-ranking spending on health care.


Carmen Kosicek, MSN, PMHNP-BC

Latest:

Closing Thoughts on the Treatment of MDD

Roger S. McIntyre, MD, FRCPC, and Carmen Kosicek, MSN, PMHNP-BC, discuss the future of MDD treatment and share closing thoughts.


Jacinda Abdul-Mutakabbir, PharmD, MPH, AAHIVP

Latest:

Vaccination Strategies Practice Pearls And Key Take Aways

Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.


Aislinn Antrim

Latest:

Impact of Pain on Daily Life Greater Threat to Mental Health than Pain Intensity, Study Finds

Mental wellbeing for some persons with chronic pain appears to be associated with the flexibility to adjust goals and persevere despite obstacles, setbacks, note study authors.


Shai Efrati, MD

Latest:

Long COVID: Hyperbaric Oxygen Therapy Offers Hope for Understanding and Treating Symptoms

Hyperbaric oxygen therapy in a randomized placebo-controlled trial resulted in improved global cognitive function, energy, sleep, and pain interference in long COVID patients.


Neil Skolnik, MD

Latest:

Vaccination Strategies Practice Pearls And Key Take Aways

Drs John Russell, Jacinda Abdul-Mutakabbir, Charles Vega, Wendy Wright, And Neil Skolnik provide their practice pearls and key thoughts on how to vaccinate their patient populations in the upcoming influenza season.


Jared Kaltwasser

Latest:

COPD Increases Risk for Heart Failure in People who Experience AMI

“Patients with COPD who have AMI are less aggressively treated than those without COPD," leading to higher in-hospital mortality and long-term mortality,” wrote authors.


Ron Southwick

Latest:

With the Flu Season in Overdrive, Hospitals are Overwhelmed

Some hospitals have EDs filled with patients and a number of states are reporting the 2024-2025 version of a COVID-19, flu, and RSV tripledemic.


Angela Fitch, MD

Latest:

Obesity-related Comorbidities and Treatment: An Overview

An overview of common and uncommon obesity-related comorbidities and treatment strategies, here.


Carolynn Francavilla, MD

Latest:

3 Ways Physicians Can Support Patients with Obesity in 2023

Three tips on how to support patients on their weight management journey this year.


Dominique R. Williams, MD, MPH

Latest:

Obesity and Depression in Adolescents: Understanding the Interplay

Understanding the interplay between obesity and depression in children is key for clinicians to best advise this patient population. An overview, here.


Anne Meneghetti, MD

Latest:

Long Colds: How to Manage Patient Expectation About Duration of the Common Cold

Patients largely underestimate how long a cold should last and the lingering symptoms too often prompt a request for antibiotics. Primary care, please resist!


Deborah Shenkman, RDLD, CDCES

Latest:

Final Thoughts on Strategies for Managing and Monitoring Patients Receiving Teplizumab

The panel concludes its discussion with key takeaways on the optimal care of patients with type 1 diabetes care and thoughts on unmet needs within the treatment space.


Stewart Tepper, MD

Latest:

Symbravo Mechanism of Action and Patient Selection, with PI Stewart Tepper, MD

Tepper, principal investigator for phase 3 trials of Symbravo as acute treatment for migraine in adults, reviews the new drug's dual MOA and target patient populations.


Silas Norman, MD, MPH

Latest:

For Unknown Causes of Kidney Disease, Genetic Testing Holds Promise

A recent American Kidney Fund survey of 300 primary care and specialty clinicians found ~15% of their patients had kidney disease of unknown origin.


Mary Caffrey

Latest:

Investigational Oral Agent Muvalaplin Reduces Lp(a) by Up to 85% in High-Risk Adults: Phase 2 Data

Lp(a) is a genetically-driven and independent risk factor for CVD with no approved treatments. Lilly is advancing muvalaplin and has some good competition.


Cameron Santoro

Latest:

5 Elemental Facts About Electronic Cigarettes All Clinicians Should Know

The 5 summaries that follow cover harmful ingredients, associated health risks, industry marketing tactics, and current regulatory efforts.



Atul Patel, MD

Latest:

When the Patient Says Pain is the Problem, Physiatry Has a Plan

The goal of a PM&R physician is to identify the source of function-limiting pain and then develop the best plan for each patient to return them to their lives.


Lisa Larkin, MD, FACP, MSCP, IF

Latest:

Guidance for PCPs: Streamlining Menopause Care

Panelists discuss strategies for simplifying complex information for primary care physicians (PCPs), provide tips on how PCPs can effectively communicate evidence-based treatment options to patients, and outline actionable points and key takeaways to enhance patient care in managing menopause symptoms.


Natalie Bellini, DNP, FNP-BC, BC-ADM, CDCES

Latest:

Key Insights and Final Thoughts on Screening and Management of T1D

Panelists discuss key insights on the importance of early screening for T1D, the role of antibody testing in identifying at-risk individuals, and the need for timely intervention to preserve ß-cell function and optimize long-term management strategies for better patient outcomes.

© 2025 MJH Life Sciences

All rights reserved.